urapidil has been researched along with Hypertrophy, Left Ventricular in 2 studies
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Puttinger, H | 1 |
| Soleiman, A | 1 |
| Oberbauer, R | 1 |
| Neuhäuser, C | 1 |
| Müller, M | 1 |
| Welters, I | 1 |
| Scholz, S | 1 |
| Kwapisz, MM | 1 |
1 trial available for urapidil and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Effect of isoflurane on echocardiographic left-ventricular relaxation indices in patients with diastolic dysfunction due to concentric hypertrophy and ischemic heart disease.
Topics: Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Antihypertensive Agents; Cardiovascular Phy | 2006 |
1 other study available for urapidil and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Regression of hypertensive nephropathy during three years of optimal blood pressure control.
Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Biopsy; Echocardiography; Emergencies; | 2003 |